Skip to main content

Table 1 General information of the study patients

From: Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease

  Mean ± SD / Median (IQR) or N (%)
Age, years 59.9 ± 14.9
Male 43 (56.6%)
BMI, kg/m2 24.7 ± 3.7
Current smoker 20 (26.3%)
Etiology
 Diabetic kidney disease 22 (28.9%)
 Hypertensive nephropathy 6 (7.9%)
 Glomerulonephritis 18 (23.7%)
 Others 7 (9.2%)
 Undetermined 23 (30.3%)
Previous CVD 32 (42.1%)
 Myocardial infarction 3 (3.9%)
 Stroke 27 (35.5)
 Coronary heart disease 6 (7.9%)
 Atrial fibrillation 2 (2.6%)
eGFR, mL/min/1.73m2 41.4 ± 25.4
Hemoglobin, g/L 112.5 ± 22.5
Albumin, g/L 36.0 ± 6.9
Total cholesterol, mmol/L 5.18 ± 2.03
Triglycerides, mmol/L 1.89 ± 1.52
HDL-C, mmol/L 1.23 ± 0.46
LDL-C, mmol/L 3.06 ± 1.23
Calcium, mmol/L 2.17 ± 0.20
Phosphorus, mmol/L 1.17 ± 0.23
CRP, mg/L 1.1 (0.5 - 4.0)
Urine PCR, mg/mmol 246.8 (55.6 – 493.3)
CNP, pg/ml 790.8 ± 309.1
  1. Abbreviations: BMI Body mass index, CNP C-type natriuretic peptide, CRP C-reactive protein, CVD Cardiovascular disease, eGFR Estimated glomerular filtration rate, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, PCR Protein to creatinine ratio